<h2 id="what-is-morphine-">What is Morphine? <sup id="fnref:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li>Naturally occurring opioid analgesic derived from the opium poppy.</li>
  <li>Used for the management of moderate to severe pain.</li>
</ul>
<h2 id="mechanism-of-action--pharmacokinetics-">Mechanism of Action &amp; Pharmacokinetics <sup id="fnref:1:1" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li>Primarily acts on mu-opioid receptors in the central nervous system (CNS) to produce analgesia.</li>
  <li>Onset in 30-60 minutes (PO) and 15 minutes (IV), with a half-life of 2-3 hours. <sup id="fnref:4" role="doc-noteref"><a href="#fn:4" class="footnote" rel="footnote">3</a></sup></li>
  <li>Binds to opioid receptors leading to inhibition of ascending pain pathways, altering the perception of and response to pain.</li>
  <li>Metabolized in the liver by glucuronidation, producing morphine-3-glucuronide (inactive) and morphine-6-glucuronide (active), the latter of which has potent analgesic effects.
    <ul>
      <li>Morphine-6-glucuronide can accumulate in renal failure, potentially causing prolonged sedation and respiratory depression. <sup id="fnref:1:2" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></li>
    </ul>
  </li>
  <li>Excreted primarily through the kidneys.</li>
</ul>
<h2 id="pharmacodynamics-">Pharmacodynamics <sup id="fnref:1:3" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:2:1" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<h3 id="cardiovascular">Cardiovascular</h3>
<ul>
  <li>May cause mild to moderate hypotension due to peripheral vasodilation (in part due to histamine release)</li>
  <li>Can also cause bradycardia due to its effects on the parasympathetic nervous system.</li>
</ul>
<h3 id="respiratory">Respiratory</h3>
<ul>
  <li>Depresses respiratory centers in the brainstem, leading to decreased respiratory rate and minute ventilation. Often, compensatory increased tidal volume occurs. <sup id="fnref:1:4" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></li>
  <li>Risk of respiratory depression increases with dose and concomitant use of other CNS depressants.</li>
</ul>
<h2 id="indications-">Indications <sup id="fnref:1:5" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup></h2>
<ul>
  <li>Management of moderate to severe pain where the use of an opioid analgesic is appropriate.</li>
  <li>Often used in postoperative pain management, cancer pain, and severe acute pain.</li>
  <li>Also used for relief of dyspnea in palliative care and management of myocardial infarction-related pain.</li>
</ul>
<h2 id="dosage-">Dosage <sup id="fnref:2:2" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li><strong>Oral:</strong>
    <ul>
      <li>10 to 30 mg every 4 hours as needed for pain.</li>
    </ul>
  </li>
  <li><strong>Intravenous (IV):</strong>
    <ul>
      <li>2.5 to 10 mg every 2 to 4 hours as needed for pain.</li>
      <li>0.05 to 0.1 mg/kg in pediatrics (IV). <sup id="fnref:5" role="doc-noteref"><a href="#fn:5" class="footnote" rel="footnote">4</a></sup></li>
    </ul>
  </li>
  <li><strong>Patient-Controlled Analgesia (PCA):</strong>
    <ul>
      <li>Initial demand dose: 1 mg IV; lockout interval typically 6 to 10 minutes.</li>
    </ul>
  </li>
  <li>Dosage should be adjusted based on the patient's response, tolerance, and severity of pain.</li>
</ul>
<h2 id="contraindications-">Contraindications <sup id="fnref:1:6" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:2:3" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup></h2>
<ul>
  <li>Hypersensitivity to morphine or any of its components.</li>
  <li>Severe respiratory depression without resuscitative equipment or monitoring.</li>
</ul>
<h2 id="complications-">Complications <sup id="fnref:1:7" role="doc-noteref"><a href="#fn:1" class="footnote" rel="footnote">1</a></sup><sup id="fnref:2:4" role="doc-noteref"><a href="#fn:2" class="footnote" rel="footnote">2</a></sup><sup id="fnref:3" role="doc-noteref"><a href="#fn:3" class="footnote" rel="footnote">5</a></sup></h2>
<ul>
  <li>Respiratory depression</li>
  <li>Common opioid-related side effects include nausea, vomiting, constipation, pruritus, and sedation.</li>
  <li>Risk of hypotension, especially in patients with compromised blood pressure or on concomitant medications that lower blood pressure.</li>
  <li>Risk of prolonged sedation in patients with renal impairment due to accumulation of morphine-6-glucuronide.</li>
</ul>
<h2 id="references">References</h2>
<div class="footnotes" role="doc-endnotes">
  <ol>
    <li id="fn:1" role="doc-endnote">
      <p>Birdi T, Sullivan P. Ottawa Anesthesia Primer. Toronto, Ontario: Echo Book Publishing; 2012. <a href="#fnref:1" class="reversefootnote" role="doc-backlink">&#8617;</a> <a href="#fnref:1:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a> <a href="#fnref:1:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a> <a href="#fnref:1:3" class="reversefootnote" role="doc-backlink">&#8617;<sup>4</sup></a> <a href="#fnref:1:4" class="reversefootnote" role="doc-backlink">&#8617;<sup>5</sup></a> <a href="#fnref:1:5" class="reversefootnote" role="doc-backlink">&#8617;<sup>6</sup></a> <a href="#fnref:1:6" class="reversefootnote" role="doc-backlink">&#8617;<sup>7</sup></a> <a href="#fnref:1:7" class="reversefootnote" role="doc-backlink">&#8617;<sup>8</sup></a></p>
    </li>
    <li id="fn:2" role="doc-endnote">
      <table>
        <tbody>
          <tr>
            <td>[[@cullenBarashCullenStoelting2024</td>
            <td>Bruce F. Cullen, Bruce F. Cullen, Barash, Cullen, and Stoelting's clinical anesthesia, 2024]]</td>
          </tr>
        </tbody>
      </table>
      <p><a href="#fnref:2" class="reversefootnote" role="doc-backlink">&#8617;</a> <a href="#fnref:2:1" class="reversefootnote" role="doc-backlink">&#8617;<sup>2</sup></a> <a href="#fnref:2:2" class="reversefootnote" role="doc-backlink">&#8617;<sup>3</sup></a> <a href="#fnref:2:3" class="reversefootnote" role="doc-backlink">&#8617;<sup>4</sup></a> <a href="#fnref:2:4" class="reversefootnote" role="doc-backlink">&#8617;<sup>5</sup></a></p>
    </li>
    <li id="fn:4" role="doc-endnote">
      <table>
        <tbody>
          <tr>
            <td>[[@pardo2017basics</td>
            <td>M. Pardo, R.D. Miller, Basics of anesthesia E-book, 2017]]</td>
          </tr>
        </tbody>
      </table>
      <p><a href="#fnref:4" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
    <li id="fn:5" role="doc-endnote">
      <table>
        <tbody>
          <tr>
            <td>[[@alma991028143802004336</td>
            <td>Coté and Lerman's a practice of anesthesia for infants and children, 2018]]</td>
          </tr>
        </tbody>
      </table>
      <p><a href="#fnref:5" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
    <li id="fn:3" role="doc-endnote">
      <p>Ducharme, S. (2020). Morphine. <em>Anesthesia &amp; Analgesia, 91</em>(5): 1224-1226. DOI: 10.1097/00000539-202005000-00034. <a href="#fnref:3" class="reversefootnote" role="doc-backlink">&#8617;</a></p>
    </li>
  </ol>
</div>